Run, Swim, Throw, Cheat
The Science Behind Drugs in Sport
Falha ao colocar no Carrinho.
Falha ao adicionar à Lista de Desejos.
Falha ao remover da Lista de Desejos
Falha ao adicionar à Biblioteca
Falha ao seguir podcast
Falha ao parar de seguir podcast
Assine e ganhe 30% de desconto neste título
R$ 19,90 /mês
Compre agora por R$ 76,99
Nenhum método de pagamento padrão foi selecionado.
Pedimos desculpas. Não podemos vender este produto com o método de pagamento selecionado
-
Narrado por:
-
Kieran Phoenix
-
De:
-
Chris Cooper
Sobre este áudio
Drugs in sport are big news and the use of performance-enhancing drugs in sport is common. Here, Chris Cooper, a top biochemist at the University of Essex, looks at the science behind drugs in sport. Using the performance of top athletes, Cooper begins by outlining the limits of human performance. Showing the basic problems of human biochemistry, physiology, and anatomy, he looks at what stops us running faster, throwing longer, or jumping higher. Using these evidence-based arguments he shows what the body can, and cannot, do. There is much curiosity about why certain substances are used, how they are detected, and whether they truly have an effect on the body. Cooper explains how these drugs work and the challenges of testing for them, putting in to context whether the 'doping' methods of choice are worth the risk or the effort.
Exploring the moral, political, and ethical issues involved in controlling drug use, Cooper addresses questions such as 'What is cheating?', 'What compounds are legal and why?', 'Why do the classification systems change all the time?', and 'Should all chemicals be legal, and what effect would this have on sport?'. Looking forward, he examines the recent work to study the physical limitations of rat and mice behaviour. He shows that, remarkably, simple genetic experiments producing 'supermice' suggest that there may be ways of improving human performance too, raising ethical and moral questions for the future of sport.
©2012 Chris Cooper (P)2013 Audible, Inc.